Updates from the Basser Research Center for BRCA
- Hollywood on Board
- Joining FORCEs 2014
- New BRCA Decision Tool
- Fertility, Reproduction, Menopause
- Updates from the Basser Research Center for BRCA
- Research Studies of Interest for the HBOC Community
- Challenges to Hereditary Cancer Research
- Voices of FORCE
- Exercise for Previvors and Survivors
- What's New @ FORCE
The Basser Research Center for BRCA of Penn Medicine’s Abramson Cancer Center was founded in 2012 with the mission of using cutting edge research to advance care for individuals with BRCA1/2 mutations.
Here’s what’s new at the Basser Center:
- Our updated website provides information on BRCA-related cancer risks and risk management, resources, news, and support.
- This summer we released over $2 million in grant funding. Research projects range from potential vaccine therapies to prevent BRCA1/2-related cancers, to optimal nutrition and exercise for BRCA-positive cancer survivors, to managing side effects associated with prophylactic removal of the ovaries. Thank you to the 600 FORCE members who have enrolled in our studies. Visit the Research tab on our website to learn more about open studies.
- The inaugural Basser Global Prize was awarded to Professor Alan Ashworth from the Institute for Cancer Research for his work using genetic principles to understand cancer biology and improve treatment.
- We are increasing awareness of BRCA1/2 in the Jewish community via a national poster campaign and outreach events. If you see a Basser Center Star of David-Pink Ribbon Poster in your synagogue or community organization, e-mail a photo to us, along with the location, to email@example.com. Visit our website to learn about local events and download fact sheets and posters.
Disclaimer: Health links are made available for educational purposes only. This information should not be interpreted as medical advice. All health information should be discussed with your health care provider. Please read our full disclaimer for more information.
This site has been made possible by a generous grant from Morphotek.